intervenn.comHealthcareFounded: 2017Funding to Date: $245.77MM
Intervenn is a biotechnology company focused on developing blood tests for early cancer detection.
For more details on financing and valuation for InterVenn, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for InterVenn.
To read this article and more news on InterVenn, register or login.
